Form 4: Liquidia Corp Director Joanna Horobin Granted 18,396 Restricted Stock Units
Insider Transaction Report
Liquidia Corp Director Joanna Horobin was granted 18,396 Restricted Stock Units (RSUs) on June 17, 2025, increasing her beneficial ownership to 38,755 shares of common stock.
Summary
- Joanna Horobin, a Director of Liquidia Corp (LQDA), acquired 18,396 shares of common stock through a grant of Restricted Stock Units (RSUs).
- The transaction date for the RSU grant was June 17, 2025.
- The RSUs convert into common stock on a one-for-one basis and were granted at a price of $0 per unit.
- Following this acquisition, Ms. Horobin's total beneficial ownership of Liquidia Corp common stock is 38,755 shares.
- The granted RSUs are set to vest upon the earlier of the one-year anniversary of the grant date (June 17, 2025) or the day prior to Liquidia Corp's next annual shareholder meeting following the grant date.
Sentiment
Score: 7
Explanation: The grant of equity to a director is generally a positive signal, indicating alignment of interests and confidence in the company's future, though it's a routine compensation event rather than a major strategic announcement.
Positives
- The grant of Restricted Stock Units to a director aligns management incentives with shareholder interests, encouraging long-term value creation.
- Increased beneficial ownership by a director can signal confidence in the company's future prospects.
Future Outlook
The vesting schedule for the granted Restricted Stock Units indicates future equity conversion for the director, aligning her long-term interests with the company's performance and potential future growth.
Industry Context
This RSU grant is a standard practice for compensating directors in the biotechnology or pharmaceutical industry, aiming to retain talent and align their interests with long-term company performance and shareholder value.
Comparison to Industry Standards
- The grant of Restricted Stock Units at a $0 price is a common form of equity compensation for directors across publicly traded companies, particularly in growth-oriented sectors like biotech.
- Such grants are generally benchmarked against peer group compensation practices to ensure competitiveness and appropriate incentive alignment, though specific comparable companies or projects are not detailed in this filing.
Stakeholder Impact
- Shareholders: The grant of RSUs to a director aligns her interests with those of shareholders, potentially encouraging long-term value creation and improved governance.
- Employees: No direct impact on general employees is indicated by this specific filing, as it pertains to director compensation.
Next Steps
- Vesting of the 18,396 Restricted Stock Units upon the earlier of June 17, 2026 (one-year anniversary of grant) or the day prior to Liquidia Corp's next annual shareholder meeting following the grant date.
Key Dates
| Date | Description |
|---|---|
| 06/17/2025 | Date of RSU grant transaction for Joanna Horobin. |
| 06/20/2025 | Signature date of the Form 4 filing by Joanna Horobin. |
Keywords
Liquidia Corp, LQDA, SEC Form 4, Insider Transaction, Restricted Stock Units, RSUs, Director Compensation, Beneficial Ownership, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.